ACRA QGEN
$53.44 -1.50 -2.81%
Today share price
USA
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Показатель: 31 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

12.11B
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

12.97B
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

0.25
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

226.57M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

-

Upcoming events

All events
No upcoming events scheduled

Stock chart

Stock analysis

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

35.94 35.35
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

3.18 2.88
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

20.19 18.32
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

1.34 1.71
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

9.36 8.30

Price change per year

45.33$ 59.00$
Min Max

Summary analysis

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure

Revenue and net income

All parameters

Stock news

All news

American Airlines fires attorneys who said 9-year-old girl 'should have known' she was being recorded in the bathroom

Проблем с обслуживанием иностранных Boeing и Airbus нет - Мантуров

Около 2 тыс. тонн черешни планируют собрать в 2024 году кубанские аграрии

Иран нарастит добычу нефти до 4 млн баррелей в сутки - агентство

Кабмин утвердил требования к организациям, которые могут управлять водными беспилотниками

Химическая индустрия способствует росту обороноспособности России - Мишустин

РФ и Узбекистан прорабатывают контракт по созданию АЭС российского дизайна

РФ и Узбекистан прорабатывают совместное строительство газохимического комплекса

Все о пенсии работающего пенсионера: сколько и как получить, индексация

"Газпром" подает газ для Европы через Украину в объеме 42,2 млн куб. м через "Суджу"

Дочерняя компания РЖД отменила поезда Ереван - Тбилиси - Ереван из-за оползня

Топ-10 самых высоких ставок по накопительным счетам до 16,5% годовых

ДОЧЕРНАЯ КОМПАНИЯ РЖД ОТМЕНИЛА РЕЙСЫ ЕРЕВАН - ТБИЛИСИ - ЕРЕВАН ИЗ-ЗА СХОДА ОПОЛЗНЯ НА ЖЕЛЕЗНОДОРОЖНЫЕ ЛИНИИ - ПРЕСС-СЛУЖБА

Ozon и терминал "Каникурган" объединят усилия по перевозкам из Китая

Mom fined $88,000 after her children collected 72 clams — not seashells — at a California beach

Woman says 'near-vertical' Disney waterslide knocked her unconscious and caused brain damage in new lawsuit

Costco has 3 ways to shop without a membership, but the math still favors paying the fee

Участниками и гостями инвестфорума в Сибае стали более 10 тыс. человек

About company

QIAGEN N.V. provides sample to insight solutions that transform biological materials into molecular insights worldwide. The company offers primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories. It also provides interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; assays for analysis of genomic variants; and assays for prenatal testing and detection of sexually transmitted diseases and HPV; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. The company offers PCR consumables, such as quantitative PCR, reverse transcription and combinations kits for analysis of gene expression, genotyping and gene regulation instruments and technologies; human ID and forensics assay consumables, including STR assays for human ID, and assays for food contamination; PCR instruments consist of digital PCR solutions; and developed and configured OEM consumables. It offers predefined and custom NGS gene panels, library prep kits and components, whole genome amplification, etc.; bioinformatics solutions; and custom laboratory and genomic services. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. The company has collaboration agreements with Amgen Inc.; CLIA-certified laboratories; NuProbe Global; and Personal Genome Diagnostics Inc., as well as a strategic alliance agreement with Sysmex Corporation. The company was founded in 1986 and is headquartered in Venlo, the Netherlands.
Address:
Hulsterweg 82, Venlo, Netherlands, 5912 PL
Company name:
Issuer ticker: QGEN
ISIN: NL0012169213
Country: USA
Exchange: ACRA
Currency: $
IPO date: 1996-06-28
Sector: Healthcare
Industry: Life Sciences Tools & Services
Site: https://www.qiagen.com

On which stock exchange are (QGEN) stocks traded?

(QGEN) stocks are traded on ACRA.

What is the ticker of stocks (QGEN)?

The stock ticker of ’s stocks or in other words, the code is QGEN. The stocks are currently listed on the ACRA exchange.

In which sector and industry does (QGEN) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, (QGEN) belongs to the «Healthcare» sector and the «Life Sciences Tools & Services» industry.

In what currency are (QGEN) stocks traded?

(QGEN) stocks are traded on the ACRA exchange in dollars.

What is the price of (QGEN) stocks today?

The current price of stocks on 26.05.2024 is 53.44 dollars. per share.

What is the dynamics of (QGEN) stocks from the beginning of the year?

(QGEN) quotes have increased by 0% from the beginning of the year up to 53.44 dollars. per 1 stocks.

How much did (QGEN) stocks increase in мае 2024?

This month (QGEN) quotes have increased by 0% to 53.44 dollars. per share.

How much are (QGEN) stocks worth?

Today, on October, 26.05.2024 ’s (QGEN) stocks cost 53.44 dollars..

What is the market capitalization of (QGEN)?

Capitalization is the market value of (QGEN) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 26.05.2024, the market capitalization of (QGEN) is estimated at about 12108007680 dollars.